Figure 5
From: PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer
Kaplan–Meier of survival of the 1592 breast cancer patients grouped by the expression of PSMB7 (200786_at probe set) above or below the median.
